South, Annabelle http://orcid.org/0000-0001-8912-2001
Snowdon, Claire
Burnett, Eva
Bierer, Barbara E.
Gillies, Katie
Isaacs, Talia
Sydes, Matthew R.
Funding for this research was provided by:
Medical Research Council (MC_UU_12023/24, MC_UU_00004/08)
Article History
Received: 1 March 2024
Accepted: 24 June 2024
First Online: 10 July 2024
Declarations
:
: The study obtained ethics approval from the London-Chelsea Research Ethics Committee, MREC number 18/LO/1011 (Additional File 6). Participants who were interviewed gave written informed consent, while questionnaires contained an embedded informed consent element, with completion and return of the questionnaire taken to indicate consent to use the data has been given. Patient interviewees received a £20 voucher to thank them for their participation. Site staff received no financial incentive to take part in the interviews. Consent to participate in the interviews included consent for use of the data collected to be used for other research in the future.
: Not applicable.
: We have read the journal’s policy and the authors of this manuscript have the following competing interests: AS, CS, EB, KG, TI and BEB have nothing to declare. BEB reports receiving consulting fees from Lilly outside the submitted work. MRS reports grants from Clovis; grants and non-financial support from Astellas, Janssen, Novartis, Pfizer and Sanofi; and personal fees from AstraZeneca, Lilly Oncology and Janssen, outside the submitted work.